Lin Tung-Yen, Lin Kuan-Yu, Kuo Hung-Yang, Huang Kuo-How, Wang Chih-Yuan, Lin Yu-Lin, Shih Shyang-Rong, Liang Po-Chin
Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
J Endocr Soc. 2022 Jun 13;6(8):bvac091. doi: 10.1210/jendso/bvac091. eCollection 2022 Aug 1.
Advanced adrenocortical carcinoma (ACC) has a poor prognosis and is often resistant to the conventional regimens of mitotane administration and systemic chemotherapy. In addition to surgery, local therapeutic measures can be valuable. Here, we present the case of a 33-year-old woman who developed left retroperitoneal local recurrent ACC with hepatic and pulmonary metastases 1 year after radical adrenalectomy. The tumors progressed under chemotherapy and mitotane treatments. She was treated with yttrium-90 selective internal radiation therapy (Y SIRT) for hepatic metastases and cryoablation of the local recurrent tumor, after which significant tumor shrinkage was observed. She then received radiofrequency ablation for the residual hepatic metastases and radiotherapy to the residual local recurrent tumor. Complete remission was achieved and maintained at least until the data cutoff day (15.8 months after the last treatment). This is the first published report of cryoablation in a patient with ACC and the third report of Y SIRT use for hepatic metastasis of ACC. Cryoablation and Y SIRT are local treatment choices for ACC that are worthy of further study.
晚期肾上腺皮质癌(ACC)预后较差,通常对米托坦给药和全身化疗的传统方案耐药。除手术外,局部治疗措施可能有价值。在此,我们报告一例33岁女性病例,该患者在根治性肾上腺切除术后1年出现左腹膜后局部复发性ACC并伴有肝和肺转移。肿瘤在化疗和米托坦治疗下进展。她接受了钇-90选择性内放射治疗(Y SIRT)用于肝转移以及对局部复发性肿瘤进行冷冻消融,之后观察到肿瘤显著缩小。然后她接受了残余肝转移灶的射频消融以及对残余局部复发性肿瘤的放射治疗。实现了完全缓解,并且至少维持到数据截止日(最后一次治疗后15.8个月)。这是首例关于ACC患者冷冻消融的发表报告,也是第三例关于Y SIRT用于ACC肝转移的报告。冷冻消融和Y SIRT是ACC的局部治疗选择,值得进一步研究。